Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...